Biomet Hip Implant Lawsuits: Bernstein Liebhard LLP Notes 141 Actions Now Pending in Federal Biomet M2a Magnum Hip Replacement Litigation
The Firm is currently investigating Biomet hip replacement lawsuits on behalf of individuals who suffered hip implant failure, metallosis and other complications allegedly due to the Biomet M2a Magnum Hip Replacement
New York, New York (PRWEB) February 02, 2013
A total of 141 Biomet hip implant lawsuits are now pending in the multidistrict litigation underway in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to a Transfer Order dated January 31, 2013, nine additional actions have been transferred to Indiana for pretrial proceedings. The Biomet hip replacement litigation was initially established by the U.S. Judicial Panel on Multidistrict Litigation in October 2012 for all federally filed claims involving the metal-on-metal Biomet M2a Magnum Hip Replacement System. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation — MDL No. 2391)
“In light of the recent attention focused on metal-on-metal hip implants and the U.S. Food & Drug Administration´s (FDA) newly released safety communication, it´s not suprising that lawsuits concerning these products are growing,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free confidential legal reviews to individuals allegedly injured by the Biomet M2a Magnum Hip device.
Metal-on-Metal Hip Implant Lawsuits
Biomet M2a Magnum Hip Replacements are metal-on-metal hip implants, a class of device that is currently the subject of an FDA safety review. Plaintiffs in Biomet hip replacement lawsuits allege the all-metal design of the M2a Magnum can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device.
Metal-on-metal hip implants were approved under the FDA´s 510(k) approval process, which does not require a device to undergo human clinical trials. On January 17th, the FDA proposed an order requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval (PMA) applications, which would make them ineligible for 510(k) clearance. The agency has also recommended that doctors consider metal ion testing for all-metal hip replacement patients who are experiencing symptoms of a failing implant, including pain, swelling, loosening of the implant, or change in the ability to walk.
In addition to Biomet, a number of other metal hip implant manufacturers have been named in lawsuits alleging the devices are prone to premature failure, and can expose patients to dangerous amounts of metal ions. The lawyers at Bernstein Liebhard LLP are actively filing claims in the multidistrict litigation established in the U.S. District Court, Northern District of Ohio, for actions involving the DePuy ASR hip implant (MDL No. 2197). The firm is also involved in the federal litigation underway in the Northern District of Texas concerning the metal-on-metal DePuy Pinnacle hip device (MDL No. 2244). Bernstein Liebhard LLP partner Jeffrey S. Grand is serving on the Plaintiffs´ Steering Committee in the Pinnacle hip litigation.
Free case evaluations are also being offered to patients impacted by the July 2012 Stryker Rejuvenate recall, and the June 2012 Smith & Nephew metal liner recall. In addition, Bernstein Liebhard LLP continues to investigate cases concerning the Wright Profemur and Conserve metal hip implants.
Individuals who have suffered metallosis, hip implant failure, and other serious complications as a result of a metal-on-metal hip replacement may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. A wealth of information about metal-on-metal hip implant lawsuits is available at Bernstein Liebhard´s website http://www.consumerinjurylawyers.com/ . For additional information, please contact one of our attorneys today by calling 1-877-779-1414.
About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs´ Hot List,” recognizing the top plaintiffs´ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
For the original version on PRWeb visit: http://www.prweb.com/releases/prwebbiomet-hip-lawsuits/biomet-m2a-magnum-hip/prweb10390145.htm